The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related Quality of Life in Multiple Sclerosis Patients
Status: Recruiting
Intervention Type: Other
Study Type: Observational
SUMMARY
Academic research project monitoring the effect of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) on multiple sclerosis-associated lower urinary tract symptoms.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subjects (male and female) aged 18 and over
• Subjects with signed informed consent
• Subjects able to undergo examination according to the protocol
• Patients indicated by neurologists to perform AHSCT or treated with the closest similar disease-modifying therapy (control group)
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 40
Treatments
Autologous hematopoietic stem cell transplantation (AHSCT)
Patients who underwent autologous hematopoietic stem cell transplantation (AHSCT).
Disease-modifying therapy
Patients who undergo disease-modifying therapy - standard treatment.
Related Therapeutic Areas
Sponsors
Leads: University Hospital Ostrava